Andover, MA, United States of America

Yan Qin

This inventor holds 1 USPTO granted patent. Top assignee: Children's Medical Center Corporation. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yan Qin. Retrieved from https://idiyas.com/inventor/yan-qin-4k8l7ouj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Yan Qin in Modulating TGF-β Functions

Introduction

Yan Qin is an accomplished inventor based in Andover, MA (US). He has made significant contributions to the field of biomedical research, particularly in the modulation of transforming growth factor beta (TGF-β) functions. His work has implications for various therapeutic applications.

Latest Patents

Yan Qin holds a patent for "Methods and compositions for modulation of transforming growth factor beta-regulated functions." This patent discloses compositions and methods for modulating the activity of TGF-β. More specifically, it focuses on the modulation of the release of active TGF-β from an LRRC33-TGF-β prodomain-TGF-β ternary complex. The methods outlined in this patent provide innovative approaches to treatment based on such modulation.

Career Highlights

Yan Qin is associated with the Children's Medical Center Corporation, where he continues to advance his research. His work is pivotal in understanding and manipulating TGF-β pathways, which are crucial in various biological processes and diseases.

Collaborations

Yan has collaborated with notable colleagues, including Timothy Alan Springer and Chafen Lu. These collaborations enhance the depth and breadth of his research, contributing to advancements in the field.

Conclusion

Yan Qin's innovative work in modulating TGF-β functions showcases his expertise and commitment to advancing biomedical research. His contributions are vital for developing new therapeutic strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…